Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

5-LO inhibitor under evaluation at SKB

Dec. 19, 1996

Dual-action compounds claimed by British Biotech

Dec. 17, 1996

Antiallergic/antiasthmatic compounds disclosed by Dainippon Ink

Dec. 16, 1996

New antitussive agent from Snow Brand Milk Products

Dec. 16, 1996

5-LO inhibitor approved by FDA

Dec. 13, 1996

Abbott reports on new PAF antagonists

Dec. 13, 1996

NK1 antagonists described by Boehringer Ingelheim

Dec. 13, 1996

Daiichi claims LTD4 antagonists for treating allergic diseases

Dec. 12, 1996

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Japanese researchers disclose substance P antagonists

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...